Table 3

Outcomes of the per-protocol analysis, objective sickness absence measured at 12 and 18 months of follow-up and questionnaire data measured at baseline (T0), 6 (T1) and 12 months (T2) of follow-up.

VariableIntervention group, ‘never started’ group excluded (n=46)Control group (n=70)β, RR, HR§ (95% CI)p Value
Objective sickness absence 0–12*
 At least once on sick leave (N, %)34 (73.9)48 (68.6)1.08 (0.85 to 1.36)0.677
 Duration (calendar days); mean (SD)/median24.29 (34.18)/11.0050.83 (75.75)/15.00−0.74 (−1.37 to −0.11)0.021
 Frequency; mean (SD)/median2.18 (1.47)/2.002.35 (1.78)/2.00−0.08 (−0.39 to 0.23)0.621
 Time to onset of first sickness absence spell (calendar days); mean (SD)165.67 (143.77)187.37 (146.42)1.18 (0.76 to 1.82)0.473
0–18
 At least one time on sick leave (N, %)39 (84.8)56 (80.0)1.06 (0.89 to 1.26)0.625
 Duration (calendar days); mean (SD)/median33.05 (51.18)/15.0062.57 (81.89)/25.50−0.64 (−1.18 to −0.10)0.021
 Frequency; mean (SD)/median2.69 (1.89)/2.002.93 (2.17)/2.00−0.08 (−0.37 to 0.20)0.569
 Time to onset of first sickness absence spell (calendar days); mean (SD)200.76 (198.97)231.19 (206.57)1.18 (0.78 to 1.77)0.441
Participants with sickness absence spell >28 calendar days; N (%)
 0–12*6 (13.0)17 (24.3)0.54 (0.23 to 1.26)0.160
 0–187 (15.2)22 (31.4)0.48 (0.23 to 1.04)0.078
Depressive complaints according to Beck Depression Inventory-II (0–63); Mean (SD)
 Baseline T018.15 (9.42)14.84 (8.11)
 T114.00 (11.50)16.30 (10.08)
 T212.31 (10.01)16.69 (11.04)
 T1–T0–4.50 (7.59)0.93 (7.06)−5.02 (−8.34 to −1.70)0.004
 T2–T0–4.66 (8.76)2.09 (9.51)−6.05 (−10.34 to −1.75)0.006
  • * Measured from baseline until 12 months of follow-up.

  • Measured from baseline until 18 months of follow-up.

  • Dichotomous variable (no/yes) with N (%) indicating ‘yes.’

  • § β (95% CI) in case of continuous variable and RR (95% CI) in case of dichotomous variable and HR in case of time to onset of first sickness absence spell.

  • Scale range.